Unlocking the power of a patient's own biology for the treatment of rare disease Investor Day October 2, 2025 Welcome Dirk Thye, M.D. Chief Executive Officer & Chief Medical Officer Quince investor day agenda | 10:00 a.m. ET | Welcome, agenda, introductions | Dirk Thye | | --- | --- | --- | | 10:05 a.m. ET | Quince overview and key investment highlights | Dirk Thye | | 10:20 a.m. ET | Overview of innovative eDSP System | Giovanni Mambrini | | 10:30 a.m. ET | eDSP lead indication: A-T and Phase 3 NEAT study ...